Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Trinidad Consulting LLC currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio's prosecution is highly concentrated, with only 1 distinct examiner and 1 distinct art unit involved in the current workload. This suggests a focused research and development effort that falls within a specific technical domain at the patent office.
The busiest examiner for this entity is MITCHELL, EDWIN COLEMAN, who is handling 1 busiest examiner pending office action. This 1 action represents the entirety of the pending prosecution for the company, making the examiner's specific feedback the primary focus for the legal team. With only 1 distinct art unit involved, the prosecution environment is consistent and lacks the complexity of dealing with multiple administrative groups.
The practitioner's strategy should be tailored to the 1 pending office action and the specific requirements of MITCHELL, EDWIN COLEMAN. Reviewing the examiner's past decisions in the Biotechnology & Pharmaceuticals area can help in preparing a more effective response. Successfully navigating the 1 pending office action with this 1 examiner is essential for advancing the company's intellectual property goals.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MITCHELL, EDWIN COLEMAN | 1 | 32.1% | +65.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17315089 | POUCHES | MITCHELL, EDWIN COLEMAN | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17315089 | POUCHES | MITCHELL, EDWIN COLEMAN | 1619 | §103DP | Final Rejection | — | Pending | May 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTrinidad Consulting LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Edwin Coleman Mitchell has the most, with 1 of Trinidad Consulting LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
